U.S. flag

An official website of the United States government

NM_001370658.1(BTD):c.622G>T (p.Asp208Tyr) AND Biotinidase deficiency

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Jan 17, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003473119.4

Allele description [Variation Report for NM_001370658.1(BTD):c.622G>T (p.Asp208Tyr)]

NM_001370658.1(BTD):c.622G>T (p.Asp208Tyr)

Gene:
BTD:biotinidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.1
Genomic location:
Preferred name:
NM_001370658.1(BTD):c.622G>T (p.Asp208Tyr)
Other names:
p.D228Y:GAT>TAT
HGVS:
  • NC_000003.12:g.15644538G>T
  • NG_008019.2:g.48187G>T
  • NG_008019.3:g.48188G>T
  • NM_000060.4:c.682G>T
  • NM_001281723.4:c.622G>T
  • NM_001281724.3:c.622G>T
  • NM_001281725.3:c.622G>T
  • NM_001323582.2:c.622G>T
  • NM_001370658.1:c.622G>TMANE SELECT
  • NM_001370752.1:c.622G>T
  • NM_001370753.1:c.399+2481G>T
  • NM_001407364.1:c.622G>T
  • NM_001407365.1:c.622G>T
  • NM_001407366.1:c.622G>T
  • NM_001407367.1:c.622G>T
  • NM_001407368.1:c.622G>T
  • NM_001407369.1:c.622G>T
  • NM_001407370.1:c.622G>T
  • NM_001407371.1:c.622G>T
  • NM_001407372.1:c.622G>T
  • NM_001407373.1:c.622G>T
  • NM_001407374.1:c.622G>T
  • NM_001407375.1:c.622G>T
  • NM_001407376.1:c.622G>T
  • NM_001407377.1:c.622G>T
  • NM_001407378.1:c.622G>T
  • NM_001407379.1:c.622G>T
  • NP_000051.1:p.Asp228Tyr
  • NP_001268652.2:p.Asp208Tyr
  • NP_001268652.2:p.Asp208Tyr
  • NP_001268653.2:p.Asp208Tyr
  • NP_001268654.1:p.Asp208Tyr
  • NP_001268654.1:p.Asp208Tyr
  • NP_001310511.1:p.Asp208Tyr
  • NP_001310511.1:p.Asp208Tyr
  • NP_001357587.1:p.Asp208Tyr
  • NP_001357681.1:p.Asp208Tyr
  • NP_001394293.1:p.Asp208Tyr
  • NP_001394294.1:p.Asp208Tyr
  • NP_001394295.1:p.Asp208Tyr
  • NP_001394296.1:p.Asp208Tyr
  • NP_001394297.1:p.Asp208Tyr
  • NP_001394298.1:p.Asp208Tyr
  • NP_001394299.1:p.Asp208Tyr
  • NP_001394300.1:p.Asp208Tyr
  • NP_001394301.1:p.Asp208Tyr
  • NP_001394302.1:p.Asp208Tyr
  • NP_001394303.1:p.Asp208Tyr
  • NP_001394304.1:p.Asp208Tyr
  • NP_001394305.1:p.Asp208Tyr
  • NP_001394306.1:p.Asp208Tyr
  • NP_001394307.1:p.Asp208Tyr
  • NP_001394308.1:p.Asp208Tyr
  • NC_000003.11:g.15686045G>T
  • NM_001281723.3:c.622G>T
  • NM_001281725.2:c.622G>T
  • NM_001323582.1:c.622G>T
  • P43251:p.Asp228Tyr
Protein change:
D208Y
Links:
UniProtKB: P43251#VAR_005115; dbSNP: rs397514380
NCBI 1000 Genomes Browser:
rs397514380
Molecular consequence:
  • NM_001370753.1:c.399+2481G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000060.4:c.682G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281723.4:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281724.3:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281725.3:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001323582.2:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001370658.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001370752.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407364.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407365.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407366.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407367.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407368.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407369.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407370.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407371.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407372.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407373.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407374.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407375.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407376.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407377.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407378.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407379.1:c.622G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Biotinidase deficiency
Synonyms:
BTD deficiency; Late-onset biotin-responsive multiple carboxylase deficiency; Biotin deficiency
Identifiers:
MONDO: MONDO:0009665; MedGen: C0220754; Orphanet: 79241; OMIM: 253260

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004211405Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jan 17, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004373059Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 8, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase gene.

Swango KL, Demirkol M, Hüner G, Pronicka E, Sykut-Cegielska J, Schulze A, Mayatepek E, Wolf B.

Hum Genet. 1998 May;102(5):571-5. Erratum in: Hum Genet 1998 Jun;102(6):712.

PubMed [citation]
PMID:
9654207
See all PubMed Citations (4)

Details of each submission

From Baylor Genetics, SCV004211405.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004373059.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 228 of the BTD protein (p.Asp228Tyr). This variant is present in population databases (rs397514380, gnomAD 0.006%). This missense change has been observed in individual(s) with partial biotinidase deficiency (PMID: 9654207; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 25035). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTD protein function. This variant disrupts the p.Asp228 amino acid residue in BTD. Other variant(s) that disrupt this residue have been observed in individuals with BTD-related conditions (PMID: 24797656; Invitae), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024